Matinas BioPharma
MTNB
MTNB
56 hedge funds and large institutions have $20.3M invested in Matinas BioPharma in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
59% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 17
Holders
56
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$71.8K | |
| 2 | +$42.5K | |
| 3 | +$35.3K | |
| 4 |
BlackRock
New York
|
+$23.9K |
| 5 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$12.1K |
Top Sellers
| 1 | -$724K | |
| 2 | -$207K | |
| 3 | -$163K | |
| 4 |
DA
DCF Advisers
Greenwich,
Connecticut
|
-$156K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$119K |